Garden Biopharmaceutical plans to establish a subsidiary in Macau to engage in the health and wellness business
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Garden Biopharmaceutical announced that the company plans to establish a subsidiary in Macau, China, primarily engaged in the research and development, production, and sales of health products, with a registered capital of 10 million Macanese Patacas. This initiative aims to leverage Macau's international platform to expand domestic and international markets. Additionally, Macau has a solid industrial foundation and policy environment for the research and development, production, and sales of health products, which is beneficial for the company's health business development
According to the Zhitong Finance APP, Garden Biopharmaceutical (300401.SZ) announced that the company plans to establish a subsidiary in Macau, China, mainly engaged in the research and development, production, and sales of health products, with a registered capital of 10 million Macanese Patacas. This initiative aims to leverage Macau's international platform to expand domestic and international markets. Additionally, Macau has a good industrial foundation and policy environment for the research and development, production, and sales of health products, which is beneficial for the company's health business development